Anti-ccr4 antibodies and methods of use therefor

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/28 (2006.01) A61K 39/395 (2006.01) C12N 5/20 (2006.01) G01N 33/577 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2358693

The present invention relates to an antibody or functional fragment thereof which binds to a mammalian (e.g., human) CC-chemokine receptor 4 (CCR4) or a portion of the receptor and blocks binding of a ligand to the receptor. The invention further relates to a method of inhibiting the interaction of a cell bearing mammalian CCR4 with a ligand thereof, and to use of the antibodies and fragments in research, therapeutic, prophylactic and diagnostic methods.

L'invention concerne un anticorps ou un fragment fonctionnel dudit anticorps, qui se fixe sur le récepteur des chimiokines CC 4 (CCR4) de mammifère (par exemple l'homme) ou sur une partie dudit récepteur et qui empêche la fixation d'un ligand sur ledit récepteur. Elle concerne également une technique qui permet d'inhiber l'interaction d'une cellule portant un récepteur CCR4 de mammifère avec le ligand dudit récepteur, ainsi que l'utilisation desdits anticorps et fragments dans les domaines de la recherche, de la thérapeutique, de la prophylaxie et du diagnostic.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Anti-ccr4 antibodies and methods of use therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-ccr4 antibodies and methods of use therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-ccr4 antibodies and methods of use therefor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1534581

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.